.
28 marzo 2019
Seattle Genetics Highlights Antibody-Drug Conjugate Innovation and Immuno-Oncology Program at the American Association for Cancer Research (AACR) Annual Meeting .
Entrada más reciente
Entrada antigua
Inicio